Literature DB >> 28818350

Candidate Quality Measures for Hand Surgery.

.   

Abstract

PURPOSE: Quality measures are tools used by physicians, health care systems, and payers to evaluate performance, monitor the outcomes of interventions, and inform quality improvement efforts. A paucity of quality measures exist that address hand surgery care. We completed a RAND/UCLA (University of California Los Angeles) Delphi Appropriateness process with the goal of developing and evaluating candidate hand surgery quality measures to be used for national quality measure development efforts.
METHODS: A consortium of 9 academic upper limb surgeons completed a RAND/UCLA Delphi Appropriateness process to evaluate the importance, scientific acceptability, usability, and feasibility of 44 candidate quality measures. These addressed hand problems the panelists felt were most appropriate for quality measure development. Panelists rated the measures on an ordinal scale between 1 (definitely not valid) and 9 (definitely valid) in 2 rounds (preliminary round and final round) with an intervening face-to-face discussion. Ratings from 1 to 3 were considered not valid, 4 to 6 as equivocal or uncertain, and 7 to 9 as valid. If no more than 2 of the 9 ratings were outside the 3-point range that included the median (1-3, 4-6, or 7-9), the panelists were considered to be in agreement. If 3 or more of the panelists' ratings of a measure were within the 1 to 3 range and 3 or more ratings were in the 7 to 9 range, the panelists were considered to be in disagreement.
RESULTS: There was agreement on 43% (19) of the measures as important, 27% (12) as scientifically sound, 48% (21) as usable, and 59% (26) as feasible to complete. Ten measures met all 4 of these criteria and were, therefore, considered valid measurements of quality. Quality measures that were developed address outcomes (patient-reported outcomes for assessment and improvement of function) and processes of care (utilization rates of imaging, antibiotics, occupational therapy, ultrasound, and operative treatment).
CONCLUSIONS: The consortium developed 10 measures of hand surgery quality using a validated methodology. These measures merit further development. CLINICAL RELEVANCE: Quality measures can be used to evaluate the quality of care provided by physicians and health systems and can inform quality and value-based reimbursement models.
Copyright © 2017 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hand surgery; performance measure; quality; quality measure; value

Mesh:

Year:  2017        PMID: 28818350     DOI: 10.1016/j.jhsa.2017.07.005

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  Minimal Clinically Important Difference After Carpal Tunnel Release Using the PROMIS Platform.

Authors:  Nikolas H Kazmers; Man Hung; Jerry Bounsanga; Maren W Voss; Abby Howenstein; Andrew R Tyser
Journal:  J Hand Surg Am       Date:  2019-05-06       Impact factor: 2.230

2.  Establishing the Minimal Clinically Important Difference and Substantial Clinical Benefit for the Pain Visual Analog Scale in a Postoperative Hand Surgery Population.

Authors:  Dustin J Randall; Yue Zhang; Haojia Li; James C Hubbard; Nikolas H Kazmers
Journal:  J Hand Surg Am       Date:  2022-05-27       Impact factor: 2.342

3.  Establishing the Substantial Clinical Benefit in a Non-Shoulder Hand and Upper Extremity Population for the QuickDASH and PROMIS Upper Extremity and Physical Function Computer Adaptive Tests.

Authors:  James C Hubbard; Yue Zhang; Yuqing Qiu; Minkyoung Yoo; Andrew R Stephens; Michelle Zeidan; Nikolas H Kazmers
Journal:  J Hand Surg Am       Date:  2022-02-23       Impact factor: 2.342

4.  Establishing the Minimal Clinically Important Difference for the PROMIS Upper Extremity Computer Adaptive Test Version 2.0 in a Nonshoulder Hand and Upper Extremity Population.

Authors:  Nikolas H Kazmers; Yuqing Qiu; Minkyoung Yoo; Andrew R Stephens; Michelle Zeidan; Yue Zhang
Journal:  J Hand Surg Am       Date:  2021-03-31       Impact factor: 2.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.